RxDoctor Payments Data

Morenikeji Buraimoh, MD

Orthopaedic Surgery · Farmington, CTNPI 1356603260

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Globus Medical at 31.8% of the total. Reporting peaked in 2022 at $6,056 and has fallen 82.6% since, to $1,054 in 2025.

$22,187in general payments, 2019–2025

Across 206 payments — averaging $107.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$7K
  • Medical Device Business Services, Inc.$6K
  • Johnson & Johnson$4K
  • Stryker$2K
  • Si-bone, Inc.$1K
  • Centinel Spine, LLC$347
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$2,70012%
  • Travel & lodging$10,12946%
  • Food & beverage$9,14641%
  • Education$2121%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,187 in reported general payments places this provider in the 80th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$38,507
Medicare patients
70
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol24$349
Gabapentin62$336
Ibuprofen15$290
Tizanidine Hcl17$121
Tramadol Hcl22$76
Prednisone32$50
Meloxicam14$21

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →